Pharmaxis FY loss increases

Pharmaceutical company posts a higher loss on increased operating expenses.

Pharmaceutical company Pharmaxis (PXS) has implemented a cost saving program as its losses grew in fiscal 2013 due to an increase in operating expenses.

In a preliminary final report, the group posted a loss of $43.537 million in fiscal 2013, 13% more than the $38.644 million loss the previous year.


SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device

Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles